Harvard Bioscience Acquires Part of CMA Microdialysis

Harvard Bioscience (Nasdaq:HBIO) has acquired the preclinical business of CMA Microdialysis AB, Sweden, a privately held company which pioneered the microdialysis technique for in vivo sampling and monitoring of organs and tissues.